COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1813: Articles 18121-18130  | Next

A New Hematological Prognostic Index For Covid-19 Severity
A. Hammadi, A., Al Jubouri, A. M., Ahmed, G., H. Hayyawi, A., Kareem, K., Gorial, F. I., Waheeb Salman, M., Ghanim, M., F. Jameel, B., Jawad, A. M., Abbas, H. M., Al-Gharawi, A. A., Al-shareef, J. I., Ali, C. L., Nasser, K. F., Y. Abdulrazaq, M.
10.1101/2021.02.11.21251285 — Posted: 2021-02-19
Accuracy of Smartphone Integrated Pulse Oximetry Meets Full FDA Clearance Standards for Clinical Use.
Browne, S. H., Bernstein, M., Bickler, P. E.
10.1101/2021.02.17.21249755 — Posted: 2021-02-18
Retrospective study of the first wave of COVID-19 in Spain: analysis of counterfactual scenarios
Steinegger, B., Granell, C., Rapisardi, G., Gomez, S., Matamalas, J., Soriano-Panos, D., Gomez-Gardenes, J., Arenas, A.
10.1101/2021.02.16.21251832 — Posted: 2021-02-18
A glimpse into the diverse cellular immunity against SARS-CoV-2
Chang, L.-J., Chang, C.-W., Liu, Y., Jiao, C., Liu, H., Chen, X.
10.1101/2021.02.17.431750 — Posted: 2021-02-18
SARS-CoV-2 nucleocapsid protein dually regulates innate immune responses
Zhao, Y., Sui, L., Wu, P., Wang, W., Tan, G., Wang, Z., Yu, Y., Hou, Z., Wang, G., Liu, Q.
10.1101/2021.02.17.431755 — Posted: 2021-02-18
Meta-analysis of orthogonal OMICs data from COVID-19 patients unveils prognostic markers and antiviral factors.
Biji, A., Swaraj, S., Khatun, O., Narayan, R., Sardar, R., Satish, D., Mehta, S., Bindhu, H., Jeevan, M., Saini, D. K., Singh, A., Gupta, D., Tripathi, S.
10.1101/2021.02.18.431825 — Posted: 2021-02-18
Rotavirus as an Expression Platform of the SARS-CoV-2 Spike Protein
Philip, A. A., Patton, J. T.
10.1101/2021.02.18.431835 — Posted: 2021-02-18
Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2
Lv, H., Tsang, O. T.-Y., So, R. T. Y., Wang, Y., Liu, H., Yip, G. K., Teo, Q. W., Lin, Y., Liang, W., Wang, J., Ng, W. W., Wilson, I. A., Peiris, M., Wu, N. C., Mok, C. K. P.
10.1101/2021.02.17.431722 — Posted: 2021-02-18
A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
Jangra, S., Landers, J. J., Rathnasinghe, R., O'Konek, J. J., Janczak, K. W., Cascalho, M., Kennedy, A. A., Tai, A. W., Baker, J. R., Schotsaert, M., Wong, P. T.
10.1101/2021.02.18.431484 — Posted: 2021-02-18
Alzheimer's-like remodeling of neuronal ryanodine receptor in COVID-19
Marks, A. R., Dridi, H., Reiken, S., Liu, X., Sittenfeld, L.
10.1101/2021.02.18.431811 — Posted: 2021-02-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).